Posted on 11/5/20
Iron Mountain (IRM) CEO, William Meaney on Q3 2020 Results - Earnings Call Transcript
Iron Mountain Incorporated (NYSE:IRM) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ETCompany ParticipantsWilliam Meaney - President, Chief Executive OfficerBarry Hytinen - Executive Vice . . .
Posted on 11/5/20
HqO and Alpha’a Bring the Visual Arts to Commercial Real Estate Leaders
HqO, the end-to-end operating system for commercial office buildings, has partnered with Alpha’a, the world’s largest
Posted on 11/5/20
States with the Quickest Weekly Unemployment Claims Recovery – Updated WalletHub Study
Despite the fact that the U.S. is experiencing an uptick in COVID-19 cases and hospitalizations, new unemployment claims decreased week-over-week on October 26, and were 89% . . .
Posted on 11/5/20
Hudson Global Reports 2020 Third Quarter Results
OLD GREENWICH, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON), a leading global total talent solutions company, announced today financial results for . . .
Posted on 11/5/20
Radius Health Third Quarter 2020 Operating Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial and operating results for the third quarter ended September . . .
Posted on 11/5/20
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today . . .
Posted on 11/5/20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 11/5/20
Imara Reports Third Quarter 2020 Financial Results and Business Highlights
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 11/5/20
EyePoint Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Corporate Developments
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 11/5/20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from . . .
Posted on 11/5/20
Intellia Therapeutics Announces Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 11/5/20
Albireo Reports Q3 2020 Financial Results and Provides Business Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today provided a . . .
Posted on 11/5/20
Dyne Therapeutics Reports Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living . . .
Posted on 11/5/20
Vericel Reports Record Third Quarter Revenues and Net Income
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today . . .
Posted on 11/5/20
Colliers International Brings to Market Brand New, First-Class Plymouth Apartment Community
Colliers International’s Multi-Family Advisory Group recently brought to market Pointe 1620, a Class A new construction, 56-unit property in the heart of Plymouth, Massachusetts. Its combination . . .
Posted on 11/5/20
Vicor Corporation Appoints Andrew D’Amico to Board
Vicor Corporation (NASDAQ: VICR) announced today the appointment of Andrew T. D’Amico to its Board of Directors, effective October 21, 2020.
Posted on 11/5/20
Repligen Reports Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its . . .
Posted on 11/5/20
Dr. Steven O’Day Joins Agenus as Chief Medical Officer
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate
Posted on 11/5/20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies . . .
Posted on 11/5/20
American Tower to Acquire InSite Wireless Group
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today announced that it has entered into a definitive agreement to acquire InSite Wireless Group, LLC, which owns, operates and . . .
Posted on 11/5/20
Sprague Resources Reports Third Quarter 2020 Results
PORTSMOUTH, N.H., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sprague Resources LP (NYSE: SRLP) today reported its financial results for the third quarter ended September 30, 2020.Third Quarter . . .
Posted on 11/5/20
Harvard Bioscience Announces Third Quarter 2020 Financial Results
HOLLISTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced financial results for the three and nine months ended September 30, . . .
Posted on 11/5/20
Cyclerion Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Updates
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of . . .
Posted on 11/5/20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
Posted on 11/5/20
Kymera Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein . . .

